denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Program: Trainee Activities and Services
Session: Career Development Lunch
Hematology Disease Topics & Pathways:
Research, Clinical trials, Acute Myeloid Malignancies, AML, APL, Clinical Research, Education, Diseases, Myeloid Malignancies
Session: Career Development Lunch
Hematology Disease Topics & Pathways:
Research, Clinical trials, Acute Myeloid Malignancies, AML, APL, Clinical Research, Education, Diseases, Myeloid Malignancies
Saturday, December 7, 2024, 11:15 AM-12:15 PM
Disclosures: Kadia: Amgen: Research Funding; Incyte: Research Funding; Rigel: Honoraria; DrenBio: Consultancy, Research Funding; ASTEX: Research Funding; Servier: Consultancy; Regeneron: Research Funding; Ascentage: Research Funding; Abbvie: Consultancy, Research Funding; Novartis: Honoraria; JAZZ: Research Funding; Cellenkos: Research Funding; AstraZeneca: Research Funding; BMS: Consultancy, Research Funding; Pfizer: Research Funding; Genentech: Consultancy, Research Funding; Sellas: Consultancy, Research Funding.